
Post
舒欣
Show original
Twist Bioscience Fiscal Q4 Net Loss Narrows, Revenue Rises; Fiscal Q1, 2027 Revenue Guidance Set
07:51 AM EST, 11/12/2026 (MT Newswires) -- Twist Bioscience (TWST) reported a fiscal Q4 net loss of $ 0.32 per share on Thursday, narrowing from a loss of $0.45 a year earlier. Analysts surveyed by FactSet expected a loss of $0.39 per share. Revenue for the fiscal quarter ended Sept. 30 was $126.6 million, up from $99 million a year earlier. Analysts expected $123.5 million. For fiscal Q1, the company expects revenue of $130 million to $132 million. Analysts expect $126.4 million. Twist Bioscience also expects fiscal 2027 revenue of $550 million to $560 million. Analysts expect $548.6 million. Shares of the company were down 7.8% in Thursday premarket activity.
Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Trending crypto
BTC/USDTBitcoin
$61,714-0.02%
ETH/USDTEthereum
$1,745.02-0.02%
SOL/USDTSolana
$72.44-0.02%
Today’s market buzz
1#Anthropic launches IPO roadshow, valuation rebounds to $1.8 trillion
Hot
2#Twenty One Capital increased its holdings by 154 BTC, marking the first time since July 2025

3#Gold fell below $3745, wiping out nearly $800 billion in market value

